One Line Pitch: Arterial Stiffness Inc. (ASI) has developed an inexpensive, portable, and non-invasive device that measures the amount of atherosclerosis a person has (plaque in their arteries).

Business Summary: ASI will participate in the formal medical market as a Tier 1 medical device. Competitive devices to measure atherosclerosis cost approximately $25,000 and require a clinician to operate. Our device has a capital cost of ~$100 and determines a person’s stiffness index in less than two minutes. We will earn revenue with a fee-for-use pricing model charging a fee every time our software is used to analyze a digital pulse wave signal.

Status: US FDA approval forecast for Q1 2020. China FDA approval forecast for Q4 2021. Early customers subject to regulatory approval. VC funded.